Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.
| Fund Name: | RA Capital Management |
| Manager | Peter Kolchinsky |
| Portfolio Value | $1,870,521,000 |
| Change This QTR | +1.21% |
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1. | WVE | 7,512,049 | $375,602 | 20.08% | ||
| 2. | ASND | 4,240,536 | $300,484 | 16.06% | ||
| 3. | SLDB | 2,689,444 | $126,888 | 6.78% | ||
| 4. | ECYT | 6,196,143 | $110,043 | +10% | 5.88% | |
| 5. | ZGNX | 1,878,768 | $93,187 | +65% | 4.98% |
| Company | Symbol | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2018-11-07 | ||||
| 2018-11-02 | ||||
| 2018-10-25 | ||||
| 2018-10-05 |
We use tracking technologies to enhance your user experience and to provide you service. By using Insider Monkey, you are giving us consent. Learn More
